Johnson & Johnson (ETR:JNJ)
163.32
-0.02 (-0.01%)
Oct 31, 2025, 5:35 PM CET
Johnson & Johnson Revenue
Johnson & Johnson had revenue of $23.99B USD in the quarter ending September 28, 2025, with 6.77% growth. This brings the company's revenue in the last twelve months to $92.15B, up 5.08% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.
Revenue (ttm)
$92.15B
Revenue Growth
+5.08%
P/S Ratio
5.01
Revenue / Employee
$667.26K
Employees
138,100
Market Cap
394.52B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 88.82B | 3.66B | 4.30% |
| Dec 31, 2023 | 85.16B | 5.17B | 6.46% |
| Jan 1, 2023 | 79.99B | 1.25B | 1.59% |
| Jan 2, 2022 | 78.74B | -3.84B | -4.65% |
| Jan 3, 2021 | 82.58B | 525.00M | 0.64% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.40B |
Johnson & Johnson News
- 4 hours ago - Best Dividend Aristocrats For November 2025 - Seeking Alpha
- 20 hours ago - Johnson & Johnson (JNJ) Seeks FDA Approval for Expanded Use of Stelara - GuruFocus
- 1 day ago - The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage - Nasdaq
- 1 day ago - Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir - Nasdaq
- 2 days ago - Noteworthy ETF Inflows: SPXL, JNJ, ABBV, HD - Nasdaq
- 3 days ago - Johnson & Johnson (JNJ) Faces Lawsuit Over Tylenol Marketing Practices - GuruFocus
- 3 days ago - Johnson & Johnson (JNJ) Initiates Pioneering Study on gMG Treatment - GuruFocus
- 3 days ago - JNJ Factor-Based Stock Analysis - Nasdaq